1. High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma
   Divya Sahu et al, 2018 CrossRef
2. Management of neuroblastoma in limited-resource settings
   Jaques van Heerden et al, 2020, WJCO CrossRef
3. Role of estrogen receptor alpha in MEHP-induced proliferation and invasion of SH-SY5Y cells
   Shuangyu Guo et al, 2021, Toxicology CrossRef
4. Development and Validation of a Prediction Model for Predicting the Prognosis of Postoperative Patients with Hepatocellular Carcinoma
   Xiaoliang Liu et al, 2022, IJGM CrossRef
5. Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
   Srinivasulu Yerukala Sathipati et al, 2019, Sci Rep CrossRef
6. Tracking changes in image‐defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form
   Tao Liu et al, 2024, Pediatric Blood & Cancer CrossRef
7. Bone marrow relapse in stage 4 neuroblastoma of children in Shanghai
   Hong Li, 2024, Am J Cancer Res CrossRef
8. METTL3-induced lncARSR aggravates neuroblastoma tumorigenic properties through stabilizing PHOX2B
   Xiangyi Meng et al, 2024, Pathology - Research and Practice CrossRef